SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remedies informs about outcome of board meeting

05 Feb 2025 Evaluate
Shree Ganesh Remedies has informed that the Board of Directors of the Company at its meeting held today i.e. February 05, 2025 has considered and approved Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine Months ended on 31st December, 2024 the financial results along with Limited Review Reports are enclosed. The Meeting of the Board of Directors of the Company commenced at 01:00 pm and concluded at 02:30 pm.


The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remed. Share Price

533.90 26.70 (5.26%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×